BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31595530)

  • 1. Resveratrol analogues present effective antileishmanial activity against promastigotes and amastigotes from distinct Leishmania species by multitarget action in the parasites.
    Antinarelli LMR; Meinel RS; Coelho EAF; da Silva AD; Coimbra ES
    J Pharm Pharmacol; 2019 Dec; 71(12):1854-1863. PubMed ID: 31595530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
    Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
    Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
    Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alkylaminoalkanethiosulfuric acids exhibit in-vitro antileishmanial activity against Leishmania (Viannia) braziliensis: a new perspective for use of these schistosomicidal agents.
    Porcino GN; Antinarelli LMR; Maia ACRG; Faria-Pinto P; Taunay-Rodrigues A; Zech Coelho PM; Nelson DL; Penido MLO; Coimbra ES; Vasconcelos EG
    J Pharm Pharmacol; 2019 Dec; 71(12):1784-1791. PubMed ID: 31579947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights about resveratrol analogs against trypanothione reductase of
    da Silva AD; Dos Santos JA; Machado PA; Alves LA; Laque LC; de Souza VC; Coimbra ES; Capriles PVSZ
    J Biomol Struct Dyn; 2019 Jul; 37(11):2960-2969. PubMed ID: 30058445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological activity, and mechanism of action of new 2-pyrimidinyl hydrazone and N-acylhydrazone derivatives, a potent and new classes of antileishmanial agents.
    Coimbra ES; Nora de Souza MV; Terror MS; Pinheiro AC; da Trindade Granato J
    Eur J Med Chem; 2019 Dec; 184():111742. PubMed ID: 31605866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of total phenolic fraction derived from extra virgin olive oil for its antileishmanial activity.
    Koutsoni OS; Karampetsou K; Kyriazis ID; Stathopoulos P; Aligiannis N; Halabalaki M; Skaltsounis LA; Dotsika E
    Phytomedicine; 2018 Aug; 47():143-150. PubMed ID: 30166099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Quinolinylhydrazone analogues kill Leishmania (Leishmania) amazonensis by inducing apoptosis and mitochondria-dependent pathway cell death.
    Granato JDT; Silva ETD; Lemos ASO; Machado PA; Midlej VDV; Antinarelli LMR; Silva Neto AFD; Souza MVN; Coimbra ES
    Chem Biol Drug Des; 2024 May; 103(5):e14535. PubMed ID: 38772877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of antileishmanial drugs activities in an ex vivo model of leishmaniasis.
    Terreros MJS; de Luna LAV; Giorgio S
    Parasitol Int; 2019 Aug; 71():163-166. PubMed ID: 30991111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Biological Activity, and Mechanism of Action of 2-Pyrazyl and Pyridylhydrazone Derivatives, New Classes of Antileishmanial Agents.
    Coimbra ES; Antinarelli LMR; de A Crispi M; Nogueira TCM; Pinheiro AC; de Souza MVN
    ChemMedChem; 2018 Jul; 13(14):1387-1394. PubMed ID: 29790287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solidagenone acts on promastigotes of L. amazonensis by inducing apoptosis-like processes on intracellular amastigotes by IL-12p70/ROS/NO pathway activation.
    Bortoleti BTDS; Gonçalves MD; Tomiotto-Pellissier F; Contato VM; Silva TF; de Matos RLN; Detoni MB; Rodrigues ACJ; Carloto AC; Lazarin DB; Arakawa NS; Costa IN; Conchon-Costa I; Miranda-Sapla MM; Wowk PF; Pavanelli WR
    Phytomedicine; 2021 May; 85():153536. PubMed ID: 33765552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
    Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
    Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis.
    Stroppa PHF; Antinarelli LMR; Carmo AML; Gameiro J; Coimbra ES; da Silva AD
    Bioorg Med Chem; 2017 Jun; 25(12):3034-3045. PubMed ID: 28433512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antileishmanial effects of Physalis angulata root extract on Leishmania infantum.
    Da Silva BJM; Pereira SWG; Rodrigues APD; Do Nascimento JLM; Silva EO
    J Integr Med; 2018 Nov; 16(6):404-410. PubMed ID: 30195443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the Antileishmanial Activity of Gold(I) and Gold(III) Compounds in L. amazonensis and L. braziliensis in Vitro.
    Minori K; Rosa LB; Bonsignore R; Casini A; Miguel DC
    ChemMedChem; 2020 Nov; 15(22):2146-2150. PubMed ID: 32830445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial compounds from Connarus suberosus: Metabolomics, isolation and mechanism of action.
    Morais LS; Dusi RG; Demarque DP; Silva RL; Albernaz LC; Báo SN; Merten C; Antinarelli LMR; Coimbra ES; Espindola LS
    PLoS One; 2020; 15(11):e0241855. PubMed ID: 33156835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.